6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide

C151H165N33O26S6 — CID 161097650

IUPAC6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide
SMILESO=C(NO)c1ccc(NC2CCCN(S(=O)(=O)c3ccc4c(c3)CCCC4)CC2)nc1.O=C(NO)c1ccc(NC2CN(C(c3ccccc3)c3ccccc3)C2)nc1.O=C(NO)c1cnc(NC2CCCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1cnc(NCC2CCCN(S(=O)(=O)c3ccc4ccccc4c3)C2)nc1.O=C(NO)c1cnc(NCC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1
InChIInChI=1S/C23H25N5O4S.C22H23N5O4S.C22H28N4O4S.C22H22N4O2.2C21H23N5O4S.C20H21N5O4S/c29-22(27-30)19-15-24-23(25-16-19)26-20-7-4-13-28(14-12-20)33(31,32)21-10-8-18(9-11-21)17-5-2-1-3-6-17;28-21(26-29)18-14-23-22(24-15-18)25-19-10-12-27(13-11-19)32(30,31)20-8-6-17(7-9-20)16-4-2-1-3-5-16;27-22(25-28)18-8-10-21(23-15-18)24-19-6-3-12-26(13-11-19)31(29,30)20-9-7-16-4-1-2-5-17(16)14-20;27-22(25-28)18-11-12-20(23-13-18)24-19-14-26(15-19)21(16-7-3-1-4-8-16)17-9-5-2-6-10-17;27-20(25-28)18-12-23-21(24-13-18)22-11-15-4-3-9-26(14-15)31(29,30)19-8-7-16-5-1-2-6-17(16)10-19;27-20(25-28)18-13-23-21(24-14-18)22-12-15-7-9-26(10-8-15)31(29,30)19-6-5-16-3-1-2-4-17(16)11-19;26-19(24-27)16-12-21-20(22-13-16)23-17-7-9-25(10-8-17)30(28,29)18-6-5-14-3-1-2-4-15(14)11-18/h1-3,5-6,8-11,15-16,20,30H,4,7,12-14H2,(H,27,29)(H,24,25,26);1-9,14-15,19,29H,10-13H2,(H,26,28)(H,23,24,25);7-10,14-15,19,28H,1-6,11-13H2,(H,23,24)(H,25,27);1-13,19,21,28H,14-15H2,(H,23,24)(H,25,27);1-2,5-8,10,12-13,15,28H,3-4,9,11,14H2,(H,25,27)(H,22,23,24);1-6,11,13-15,28H,7-10,12H2,(H,25,27)(H,22,23,24);1-6,11-13,17,27H,7-10H2,(H,24,26)(H,21,22,23)
InChIKeyUHZRXLNINCJKAE-UHFFFAOYSA-N
MW3050.59 g/mol
LogP17.80
Rot. Bonds40

About 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide

6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide (PubChem CID 161097650) has the molecular formula C151H165N33O26S6 and a molecular weight of 3050.59 g/mol. Its IUPAC name is 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide.

Molecular Properties

Compound Name6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide
PubChem CID161097650
Molecular FormulaC151H165N33O26S6
Molecular Weight3050.59 g/mol
Exact Mass3048.09
IUPAC Name6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide
SMILESO=C(NO)c1ccc(NC2CCCN(S(=O)(=O)c3ccc4c(c3)CCCC4)CC2)nc1.O=C(NO)c1ccc(NC2CN(C(c3ccccc3)c3ccccc3)C2)nc1.O=C(NO)c1cnc(NC2CCCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1cnc(NCC2CCCN(S(=O)(=O)c3ccc4ccccc4c3)C2)nc1.O=C(NO)c1cnc(NCC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1
InChIInChI=1S/C23H25N5O4S.C22H23N5O4S.C22H28N4O4S.C22H22N4O2.2C21H23N5O4S.C20H21N5O4S/c29-22(27-30)19-15-24-23(25-16-19)26-20-7-4-13-28(14-12-20)33(31,32)21-10-8-18(9-11-21)17-5-2-1-3-6-17;28-21(26-29)18-14-23-22(24-15-18)25-19-10-12-27(13-11-19)32(30,31)20-8-6-17(7-9-20)16-4-2-1-3-5-16;27-22(25-28)18-8-10-21(23-15-18)24-19-6-3-12-26(13-11-19)31(29,30)20-9-7-16-4-1-2-5-17(16)14-20;27-22(25-28)18-11-12-20(23-13-18)24-19-14-26(15-19)21(16-7-3-1-4-8-16)17-9-5-2-6-10-17;27-20(25-28)18-12-23-21(24-13-18)22-11-15-4-3-9-26(14-15)31(29,30)19-8-7-16-5-1-2-6-17(16)10-19;27-20(25-28)18-13-23-21(24-14-18)22-12-15-7-9-26(10-8-15)31(29,30)19-6-5-16-3-1-2-4-17(16)11-19;26-19(24-27)16-12-21-20(22-13-16)23-17-7-9-25(10-8-17)30(28,29)18-6-5-14-3-1-2-4-15(14)11-18/h1-3,5-6,8-11,15-16,20,30H,4,7,12-14H2,(H,27,29)(H,24,25,26);1-9,14-15,19,29H,10-13H2,(H,26,28)(H,23,24,25);7-10,14-15,19,28H,1-6,11-13H2,(H,23,24)(H,25,27);1-13,19,21,28H,14-15H2,(H,23,24)(H,25,27);1-2,5-8,10,12-13,15,28H,3-4,9,11,14H2,(H,25,27)(H,22,23,24);1-6,11,13-15,28H,7-10,12H2,(H,25,27)(H,22,23,24);1-6,11-13,17,27H,7-10H2,(H,24,26)(H,21,22,23)
InChIKeyUHZRXLNINCJKAE-UHFFFAOYSA-N
XLogP17.80
TPSA811.72 Ų
H-Bond Donors21
H-Bond Acceptors46
Rotatable Bonds40
Heavy Atoms216
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003050.59
LogP ≤ 517.80
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1046

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide?
The IUPAC name of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide (CID 161097650) is 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide.
What is the SMILES notation for 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide?
The canonical SMILES for 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide is O=C(NO)c1ccc(NC2CCCN(S(=O)(=O)c3ccc4c(c3)CCCC4)CC2)nc1.O=C(NO)c1ccc(NC2CN(C(c3ccccc3)c3ccccc3)C2)nc1.O=C(NO)c1cnc(NC2CCCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1cnc(NCC2CCCN(S(=O)(=O)c3ccc4ccccc4c3)C2)nc1.O=C(NO)c1cnc(NCC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.
What is the InChIKey of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide?
The InChIKey is UHZRXLNINCJKAE-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H25N5O4S.C22H23N5O4S.C22H28N4O4S.C22H22N4O2.2C21H23N5O4S.C20H21N5O4S/c29-22(27-30)19-15-24-23(25-16-19)26-20-7-4-13-28(14-12-20)33(31,32)21-10-8-18(9-11-21)17-5-2-1-3-6-17;28-21(26-29)18-14-23-22(24-15-18)25-19-10-12-27(13-11-19)32(30,31)20-8-6-17(7-9-20)16-4-2-1-3-5-16;27-22(25-28)18-8-10-21(23-15-18)24-19-6-3-12-26(13-11-19)31(29,30)20-9-7-16-4-1-2-5-17(16)14-20;27-22(25-28)18-11-12-20(23-13-18)24-19-14-26(15-19)21(16-7-3-1-4-8-16)17-9-5-2-6-10-17;27-20(25-28)18-12-23-21(24-13-18)22-11-15-4-3-9-26(14-15)31(29,30)19-8-7-16-5-1-2-6-17(16)10-19;27-20(25-28)18-13-23-21(24-14-18)22-12-15-7-9-26(10-8-15)31(29,30)19-6-5-16-3-1-2-4-17(16)11-19;26-19(24-27)16-12-21-20(22-13-16)23-17-7-9-25(10-8-17)30(28,29)18-6-5-14-3-1-2-4-15(14)11-18/h1-3,5-6,8-11,15-16,20,30H,4,7,12-14H2,(H,27,29)(H,24,25,26);1-9,14-15,19,29H,10-13H2,(H,26,28)(H,23,24,25);7-10,14-15,19,28H,1-6,11-13H2,(H,23,24)(H,25,27);1-13,19,21,28H,14-15H2,(H,23,24)(H,25,27);1-2,5-8,10,12-13,15,28H,3-4,9,11,14H2,(H,25,27)(H,22,23,24);1-6,11,13-15,28H,7-10,12H2,(H,25,27)(H,22,23,24);1-6,11-13,17,27H,7-10H2,(H,24,26)(H,21,22,23).
What are the key properties of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide?
6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide has a molecular weight of 3050.59 g/mol, XLogP of 17.80, 40 rotatable bonds, 21 hydrogen bond donors, and 46 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylazepan-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide;N-hydroxy-6-[[1-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)azepan-4-yl]amino]pyridine-3-carboxamide is sourced from PubChem (CID 161097650), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).